Pfizer's vaccine business cooled off, and it is on its back foot in the GLP-1 race, but don't count the drug giant out.

Pfizer's dividend payout ratio is high, but the company is generated enough free cash flow to cover its dividend. Management remains committed to the dividend program despite Pfizer facing a patent ...

A high-yielding payout hasn't been enough reason for investors to buy Pfizer's stock. The pharmaceutical giant's valuation has been cut in half in just three years. Investors appear to be worried ...

We just covered the 15 Safe Stocks to Invest In For Beginners and Pfizer Inc. (NYSE:PFE) ranks 14th on this list. Pfizer Inc.

The company has increased its payouts over the past five years despite significant challenges.

In new data released by the Food and Drug Administration on Wednesday, Pfizer said vaccine booster shots would restore protection against COVID-19 to up to 95% in real-world settings, CNBC and ABC ...

How many profitable, large-cap healthcare companies pay a dividend yield of over 5%? Only one. Pfizer (NYSE: PFE) checks off all the boxes. It's profitable, raking in earnings of over $9.4 billion in ...